DOCSLIB.ORG

FTSE Emerging Markets All Cap China a Inclusion

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
FTSE Emerging Markets All Cap China a Inclusion FTSE PUBLICATIONS FTSE Emerging Markets All Cap 19 February 2016 China A Inclusion Indicative Index Weight Data as at Closing on 31 December 2015 Index Index Index Constituent Country Constituent Country Constituent Country weight (%) weight (%) weight (%) 361 Degrees International (P Chip) 0.01 CHINA Ajisen China Holdings (P Chip) 0.01 CHINA Anhui Golden Seed Winery (A) <0.005 CHINA 3SBio (P Chip) 0.03 CHINA Akbank 0.13 TURKEY Anhui Gujing Distillery (A) <0.005 CHINA A.G.V. Products <0.005 TAIWAN Akcansa Cimento 0.01 TURKEY Anhui Gujing Distillery (B) 0.01 CHINA ABB India 0.02 INDIA Akenerji Elektrik Uretim <0.005 TURKEY Anhui Guofeng Plastic Industry (A) <0.005 CHINA Abbott India 0.01 INDIA AKFEN Holding 0.01 TURKEY Anhui Heli (A) <0.005 CHINA Ability Enterprise <0.005 TAIWAN AKR Corporindo Tbk PT 0.02 INDONESIA Anhui Hengyuan Coal Industry & Electricity <0.005 CHINA Aboitiz Equity Ventures 0.08 PHILIPPINES Aksa Akrilik Ve Kimya Sanayii 0.01 TURKEY Power (A) Aboitiz Power 0.04 PHILIPPINES Aksa Enerji Uretim AS 0.01 TURKEY Anhui Honglu Steel Construction (group) (A) <0.005 CHINA Abu Dhabi Commercial Bank 0.09 UAE Aksigorta <0.005 TURKEY Anhui Huamao Textile (A) <0.005 CHINA Abu Dhabi Islamic Bank Egypt <0.005 EGYPT Alam Sutera Realty 0.01 INDONESIA Anhui Huaxing Chemical Industry (A) 0.01 CHINA AcBel Polytech 0.01 TAIWAN Alarko Hldgs <0.005 TURKEY Anhui Huilong Agricultural Means of <0.005 CHINA ACC 0.03 INDIA Albaraka Turk Katilim Bankasi AS <0.005 TURKEY Production (A) Accelink Technologies (A) <0.005 CHINA Aldar Properties PJSC 0.06 UAE Anhui Jianghuai Automotive Chassis (A) <0.005 CHINA Accton Technology 0.01 TAIWAN Alembic Pharmaceuticals 0.01 INDIA Anhui Jiangnan Chemical Industry (A) <0.005 CHINA Ace Hardware Indonesia 0.01 INDONESIA Alexander Forbes Equity Holdings 0.01 SOUTH Anhui Jingcheng Copper Share (A) <0.005 CHINA Acer 0.03 TAIWAN Proprietary AFRICA Anhui Jinhe Industrial (A) <0.005 CHINA Aces Electronic Co. Ltd. <0.005 TAIWAN Alfa SAB de CV 0.16 MEXICO Anhui Liuguo Chemical (A) <0.005 CHINA Acron JSC 0.01 RUSSIA Ali <0.005 TAIWAN Anhui Quanchai Engine (A) <0.005 CHINA Adana Cimento(A) <0.005 TURKEY Aliansce Shopping Centers SA 0.01 BRAZIL Anhui Shanying Paper Industry (A) <0.005 CHINA Adani Enterprises 0.01 INDIA Alibaba Health Information Technology (P 0.06 CHINA Anhui Sierte Fertilizer Industry (A) <0.005 CHINA Adani Ports and Special Economic Zone 0.09 INDIA Chip) Anhui Sinonet & Xinlong Science & <0.005 CHINA Technology (A) Adani Power 0.01 INDIA Alibaba Pictures Group (P Chip) 0.09 CHINA Anhui Sun-Create Electronics (A) <0.005 CHINA Adaro Energy PT 0.01 INDONESIA Alior Bank SA 0.02 POLAND Anhui Tongfeng Electronics (A) <0.005 CHINA A-Data Technology 0.01 TAIWAN Allahabad Bank <0.005 INDIA Anhui Wanwei Updated High-Tech Material <0.005 CHINA Adcock Ingram Holdings 0.01 SOUTH Alliance Financial Group 0.03 MALAYSIA Industry (A) AFRICA Alliance Global 0.04 PHILIPPINES Anhui Water Resources Development (A) <0.005 CHINA Adcorp Holdings <0.005 SOUTH Almacenes Exito 0.03 COLOMBIA AFRICA Alpargatas SA PN 0.01 BRAZIL Anhui Wenergy (A) <0.005 CHINA Aditya Birla Nuvo 0.03 INDIA Alpek S.A.B. 0.01 MEXICO Anhui Xinhua Media (A) <0.005 CHINA Adlink Technology 0.01 TAIWAN Alpha Networks <0.005 TAIWAN Anhui Xinke New Materials (A) <0.005 CHINA Administradora Fibra Danhos S.A. de C.V. 0.01 MEXICO ALROSA ao 0.04 RUSSIA Anhui Yingliu Electromechanical (A) <0.005 CHINA Advanced Ceramic X 0.01 TAIWAN Alsea S.A.B. de C.V. 0.05 MEXICO Anhui Zhongding Sealing Parts (A) 0.01 CHINA Advanced Info Serv 0.14 THAILAND Alstom India <0.005 INDIA Anta Sports Products (P Chip) 0.07 CHINA Advanced International Multitech <0.005 TAIWAN Alstom T&D India 0.01 INDIA Anxin Trust (A) 0.01 CHINA Advanced Semiconductor Engineering 0.2 TAIWAN Altek Corp <0.005 TAIWAN Anyang Iron & Steel (A) <0.005 CHINA Advanced Technology & Materials (A) <0.005 CHINA Aluminum Corp of China (A) 0.01 CHINA Anyuan Coal Industry Group (A) <0.005 CHINA Advanced Wireless Semiconductor 0.01 TAIWAN Aluminum Corp of China (H) 0.04 CHINA AP Thailand <0.005 THAILAND Advantech 0.06 TAIWAN Alupar Investimento S.A. 0.01 BRAZIL Apeloa Pharmaceutical (A) <0.005 CHINA AECI 0.02 SOUTH Amanat Holdings PJSC 0.01 UAE Apex Technology (A) <0.005 CHINA AFRICA Amara Raja Batteries 0.02 INDIA Apollo Hospitals Enterprise 0.05 INDIA Aeolus Tyre (A) <0.005 CHINA Amata Corp 0.01 THAILAND Apollo Tyres 0.02 INDIA Aeroflot 0.01 RUSSIA Ambassador Hotel 0.01 TAIWAN Arab Cotton Ginning <0.005 EGYPT Aerospace Communications Holdings (A) <0.005 CHINA Ambev SA 0.6 BRAZIL Arabtec Holding PJSC 0.02 UAE Aerospace Hi-Tech (A) <0.005 CHINA Ambuja Cements 0.05 INDIA ARAMEX 0.01 UAE Aerospace Industrial Development <0.005 TAIWAN Amer Group <0.005 EGYPT Arca Continental SAB de CV 0.05 MEXICO Aerosun (A) <0.005 CHINA America Movil L 0.55 MEXICO Arcelik 0.02 TURKEY AES Gener S.A. 0.03 CHILE AMMB Holdings 0.06 MALAYSIA ArcelorMittal South Africa Ltd <0.005 SOUTH AFRICA AES Tiete On 0.01 BRAZIL Amtek Auto <0.005 INDIA Ardentec 0.01 TAIWAN AES Tiete Pref 0.01 BRAZIL AmTRAN Technology 0.01 TAIWAN Arezzo Industria e Comercio SA 0.01 BRAZIL African Rainbow Minerals Ltd 0.01 SOUTH Anadolu Cam <0.005 TURKEY Arteris SA <0.005 BRAZIL AFRICA Anadolu Efes 0.04 TURKEY Arvind 0.02 INDIA Afyon Cimento <0.005 TURKEY Anadolu Hayat <0.005 TURKEY Aselsan Elektronik Sanayi 0.01 TURKEY Agile Property Holdings (P Chip) 0.02 CHINA Andhra Bank <0.005 INDIA Ashok Leyland 0.04 INDIA Agricultural Bank of China (A) 0.08 CHINA Andon Health (A) <0.005 CHINA Asia Cement 0.05 TAIWAN Agricultural Bank of China (H) 0.3 CHINA Aneka Tambang 0.01 INDONESIA Asia Optical 0.01 TAIWAN AGTHIA GROUP PJSC 0.01 UAE Angang Steel (A) <0.005 CHINA Asia Pacific Telecom 0.02 TAIWAN Aguas Andinas S.A. A 0.04 CHILE Angang Steel (H) 0.01 CHINA Asia Polymer Corp <0.005 TAIWAN Agung Podomoro Land Tbk PT <0.005 INDONESIA Angel Yeast (A) <0.005 CHINA Asia Vital Components 0.01 TAIWAN AIA Engineering 0.01 INDIA Anglo American Platinum 0.02 SOUTH Air Arabia 0.02 UAE AFRICA Asian Paints 0.11 INDIA Air China (A) 0.01 CHINA Anglogold Ashanti 0.08 SOUTH Asian Star Anchor Chain Jiangsu (A) <0.005 CHINA Air China (H) 0.04 CHINA AFRICA Aspen Pharmacare Holdings 0.19 SOUTH AirAsia 0.01 MALAYSIA Anhui Chaodong Cement (A) <0.005 CHINA AFRICA AirAsia X <0.005 MALAYSIA Anhui Conch Cement (A) 0.01 CHINA Asseco Poland SA 0.03 POLAND Airports of Thailand 0.12 THAILAND Anhui Conch Cement (H) 0.09 CHINA Assore Ltd <0.005 SOUTH AFRICA Airtac International Group 0.02 TAIWAN Anhui Expressway (A) <0.005 CHINA Astra Agro Lestari 0.01 INDONESIA Aisino Corporation (A) 0.01 CHINA Anhui Expressway (H) 0.01 CHINA Astra International 0.25 INDONESIA Ajanta Pharma 0.01 INDIA Anhui Fangxing Science&Technology (A) <0.005 CHINA Source: FTSE Group 1 of 15 19 February 2016 Index Index Index Constituent Country Constituent Country Constituent Country weight (%) weight (%) weight (%) Astral Foods Ltd 0.01 SOUTH Barloworld 0.02 SOUTH Bharti Infratel 0.1 INDIA AFRICA AFRICA Bidvest Group 0.19 SOUTH Astro Malaysia Holdings 0.04 MALAYSIA Bashneft OAO 0.02 RUSSIA AFRICA Asustek Computer Inc 0.17 TAIWAN Bashneft Pref OAO 0.01 RUSSIA Big C Supercenter 0.06 THAILAND Asya Katilim Bankasi AS 0.01 TURKEY Basso Industry 0.01 TAIWAN BIM Birlesik Magazalar 0.11 TURKEY Aten International 0.01 TAIWAN Bayer Cropscience 0.01 INDIA Bimb Holdings 0.01 MALAYSIA Atlas Consolidated Mining and Development <0.005 PHILIPPINES BB Seguridade Participacoes S.A. ON 0.1 BRAZIL Biocon 0.01 INDIA Attacq Limited 0.02 SOUTH BBMG (A) 0.01 CHINA Biostime International Holdings (P Chip) 0.01 CHINA AFRICA BBMG (H) 0.02 CHINA Bisi International PT <0.005 INDONESIA Attock Petroleum <0.005 PAKISTAN BDO Unibank 0.09 PHILIPPINES Bizim Toptan Satis Magazalari AS <0.005 TURKEY AU Optronics 0.07 TAIWAN BEC World 0.02 THAILAND Bizlink Holding 0.01 TAIWAN AUCMA (A) <0.005 CHINA Befar Group (A) <0.005 CHINA Black Peony (A) <0.005 CHINA Aurobindo Pharmaceuticals 0.1 INDIA Beibuwan Port (A) <0.005 CHINA Blackcow Food (A) <0.005 CHINA Aveng <0.005 SOUTH Beih-Property (A) <0.005 CHINA Bloomberry Resorts 0.01 PHILIPPINES AFRICA Beijing Aerospace Changfen (A) <0.005 CHINA Blue Dart Express 0.02 INDIA AVI 0.05 SOUTH Beijing Bashi Media (A) <0.005 CHINA Blue Label Telecoms Ltd. 0.01 SOUTH AFRICA Beijing BDStar Navigation (A) <0.005 CHINA AFRICA Avianca Holdings S.A. 0.01 COLOMBIA Beijing Bewinner Communications (A) <0.005 CHINA Blue Star New Chemical Material (A) <0.005 CHINA AVIC Aero-Engine Controls (A) <0.005 CHINA Beijing Capital (A) 0.01 CHINA BM&F Bovespa 0.13 BRAZIL Avic Aircraft (A) 0.01 CHINA Beijing Capital Development (A) 0.01 CHINA BOE Technology Group (A) 0.02 CHINA Avic Aviation Engine (A) 0.02 CHINA Beijing Capital International Airport (H) 0.05 CHINA Boe Technology Group (B) 0.01 CHINA AVIC Electromechanical (A) <0.005 CHINA Beijing Capital Land (H) 0.01 CHINA Boer Power Holdings (P Chip) 0.01 CHINA Avic Heavy Machinery (A) <0.005 CHINA Beijing Capital Retailing (A) <0.005 CHINA Bohai Leasing (A) 0.01 CHINA AVIC International Holding HK (Red Chip) 0.01 CHINA Beijing Centergate Technologies (A) <0.005 CHINA Bolsa Mexicana de Valores SAB de CV 0.02 MEXICO AVIC Investment Holdings (A) 0.01 CHINA Beijing Dabeinong Technology Group (A) 0.01 CHINA Boryszew <0.005 POLAND Avic Real Estate Holding (A) <0.005 CHINA Beijing Dalong Weiye Real Estate <0.005 CHINA Bosch 0.06 INDIA AviChina Industry & Technology (H) 0.05 CHINA Development (A) Bosideng International Holdings (P Chip) 0.01 CHINA Axiata Group Bhd 0.19 MALAYSIA Beijing Electronic Zone Investment and <0.005 CHINA BR Malls Participacoes S/A Ord 0.03 BRAZIL Axis Bank 0.15 INDIA Development (A) BR Properties SA ON 0.01 BRAZIL Ayala Corporation 0.11 PHILIPPINES Beijing Enterprises Holdings (Red Chip) 0.09 CHINA Bradespar S.A.
Load more

Recommended publications
  • Potential Opportunities from One of the Fastest Growing Major Global Healthcare Markets1
    KURE 3/31/2018 China Healthcare: Potential Opportunities From One Of The Fastest Growing Major Global Healthcare Markets1 An Overview of the KraneShares MSCI All China Health Care Index ETF (Ticker: KURE) 1. Major healthcare markets defined as top five global markets by the World Health Organization. Data from the World Health Organization as of 12/31/2015. Retrieved 3/31/2018 [email protected] 1 Introduction to KraneShares About KraneShares Krane Funds Advisors, LLC is the investment manager for KraneShares ETFs. Our suite of China focused ETFs provides investors with solutions to capture China’s importance as an essential element of a well-designed investment portfolio. We strive to provide innovative, first to market strategies that have been developed based on our strong partnerships and our deep knowledge of investing. We help investors stay up to date on global market trends and aim to provide meaningful diversification. Krane Funds Advisors, LLC is majority owned by China International Capital Corporation (CICC). 2 Investment Strategy: KURE seeks to measure the performance of MSCI China All Shares Health Care 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the health care sector. The KURE securities in the Index include all types of publicly issued shares of Chinese issuers, which are listed in Mainland China, Hong Kong and United States. Issuers eligible for inclusion must be classified under the Global Industry Classification Standard (GICS) as engaged in the healthcare sector. The issuers included in the Underlying Index may include small-cap, mid-cap and large-cap companies.
    [Show full text]
  • Interview with Beijing Tong Ren Tang/Science Arts
    [ Interview ] Mr Tan Lee Huak, owner of Science Arts Co Pte Ltd. Interview with Beijing Tong Ren Tang/Science Arts eijing Tongrentang, was founded in Kangxi 8. It is a famous time-honored brand in the Traditional Chinese Medicine industry. Science Arts collaborated Bwith Beijing Tong Ren Tang in 2004 and brought this well established brand to Singapore. Beijing Tong Ren Tang has a long Beijing Tong Ren Tang has outlets in many countries in the Asia history, being founded in the Kangxi Pacific. Its headquaters is in Beijing, China. The company has period, in 1669. Can you share with collaborated with more than 20 distributors worldwide. They us how the collaboration between have stores in the UK, Australia, Canada and countries in the Asia Pacific. Beijing Tong Ren Tang and Science It has also partnered with various distributors and companies in different Arts came about? countries. In Malaysia, they have partnered with “Hai Ou” to distibute their products. Here in Singapore, Science Arts is its sole distributor. Science Arts and Beijing Tong Ren Tang went into a collaboration in 2004. 1146 ■ Volume 11 > Number 16 > 2007 www.asiabiotech.com [ Interview ] What is Science Arts history and Science Arts have been around for 30 odd years. It was set up how did it come about? by a group of young passionate fresh graduates from The Chinese High School in the 1960s. The collaboration with Beijing Tong Ren Tang is 51% stakes held by Science Arts and 49% belongs to Beijing Tong Ren Tang. What are some of the measures that The side effects of most of our products are minimal.
    [Show full text]
  • Healthcare Sector
    19 August 2013 Sector Weekly Healthcare Sector Healthcare Sector Weekly Dose Valuation summary Company Ticker CCY Px Mkt ––––– P/E ––––– EPS CAGR –––– PEG –––– –––– P/B –––– –––– ROE –––– This weekly product is designed to provide investors with key sector cap '13E '14E '15E ('12E -'15E) '13E '14E '15E '13E '14E '15E '13E '14E '15E updates and our attempt to identify (USD) (x) (x) (x) (%) (x) (x) (x) (x) (x) (x) (%) (%) (%) stock implications and insights. Shandong Weigao Group Medical 1066 -HK HKD 8.09 1,965 24.2 19.9 16.4 22 1.1 0.9 0.7 2.9 2.6 2.3 12.1 13.2 14.3 Polymer Co. Ltd. Class H Topics this week: Bribery investigation, China Shineway Pharmaceutical 2877 -HK HKD 12.72 1,356 11.8 10.5 9.4 12 1.0 0.9 0.8 1.8 1.7 1.5 16.0 16.3 16.5 H7N9 resurfacing, NDRC might adjust Group Limited originator drug px, June ’13 hospital United Laboratories International 3933 -HK HKD 2.92 613 18.3 13.0 10.6 26 0.7 0.5 0.4 0.7 0.7 0.7 3.8 5.2 6.1 patient traffic data Holdings Ltd. Sinovac Biotech Ltd. SVA -US USD 4.61 254 -26.3 -43.9 46.1 2.3 2.6 2.7 -8.7 -6.0 5.9 Companies mentioned: Weigao (1066-HK), Shineway (2877.HK) and The China Nepstar Chain Drugstore NPD -US USD 1.58 156 21.3 Ltd. Sponsored ADR United Labs (3933.HK), Sinovac (SVA.O) and Nepstar (NPD.N) Source: Factset/Bloomberg SAIC anti-bribery investigation to begin: The State Administration for Industry and Commerce (SAIC) has initiated a round of bribery investigation that is expected to last 3 months until November ‘13.
    [Show full text]
  • VANGUARD INTERNATIONAL EQUITY INDEX FUNDS Form N-Q
    SECURITIES AND EXCHANGE COMMISSION FORM N-Q Quarterly schedule of portfolio holdings of registered management investment company filed on Form N-Q Filing Date: 2018-09-28 | Period of Report: 2018-07-31 SEC Accession No. 0000932471-18-007167 (HTML Version on secdatabase.com) FILER VANGUARD INTERNATIONAL EQUITY INDEX FUNDS Mailing Address Business Address PO BOX 2600 PO BOX 2600 CIK:857489| IRS No.: 000000000 | State of Incorp.:DE | Fiscal Year End: 1031 V26 V26 Type: N-Q | Act: 40 | File No.: 811-05972 | Film No.: 181093806 VALLEY FORGE PA 19482 VALLEY FORGE PA 19482 6106691000 Copyright © 2018 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT COMPANY Investment Company Act file number: 811-05972 Name of Registrant: VANGUARD INTERNATIONAL EQUITY FUNDS Address of Registrant: P.O. Box 2600 Valley Forge, PA 19482 Name and address of agent for service: Anne E. Robinson, Esquire P.O. Box 876 Valley Forge, PA 19482 Date of fiscal year end: October 31 Date of reporting period: July 31, 2018 Item 1: Schedule of Investments Vanguard Pacific Stock Index Fund Schedule of Investments (unaudited) As of July 31, 2018 Market Value Shares ($000) Common Stocks (99.6%)1 Australia (16.6%) Commonwealth Bank of Australia 1,856,264 103,370 BHP Billiton Ltd. 3,386,626 88,447 Westpac Banking Corp. 3,610,167 79,036 CSL Ltd. 475,901 69,628 Australia & New Zealand Banking Group Ltd.
    [Show full text]
  • Completing the Deal
    termsheet April 2018 Issue 24 Completing the Deal industry insight An Interview with Dr Fintan Walton, Are Traditional Chinese Medicines Founder and Chief Executive of PharmaVentures and Plant Extract Treatments the Basis of New Licensing and M&A As Fintan Walton, the Founder and CEO of PharmaVentures, puts it himself, Growth? he was “fortunate enough to be able to enter the world of pharmaceuticals Eric Liu when the explosion of biotechnology Business Analyst, PharmaVentures Limited took off in the 1970’s and 1980s”. He Traditional Chinese Medicines (TCMs) are gaining was educated at Trinity College, Dublin interest worldwide. However despite being as a geneticist and entered the world practised by significant numbers of people in more of biotechnology in the UK by joining Celltech, the first biotech than 140 countries, the absence of robust evidence of efficacy in Europe, in the early 1980s. What Fintan finds fascinating about and safety in conventional clinical trials remains a key challenge that period was that the technology being developed enabled in mainstream commercial adoption, through licensing and M&A scientists to really understand the basis of disease and hence, transactions. Against this backdrop 2017 was a milestone year. The come up with truly break-through medicines as more and more University of Oxford opened its first Chinese Medicine Research biotech companies emerged worldwide. “Their research led to Centre on 6th December, which is one of the first research centres inventions and so the opportunity to license patents and do deals in the West that solely focuses on the study of herbal extracts became a real driver in the biotech industry”.
    [Show full text]
  • About the China Academy of Chinese Medical Sciences About the Coca-Cola Company
    [ Industry Watch ] About the China Academy of Chinese Medical Sciences The China Academy of Chinese Medical Sciences is China’s national center for research, healthcare and education in traditional Chinese medicine. It is administered under the Ministry of Public Health through the State Administration of Traditional Chinese Medicine of the People’s Republic of China. The academy employs 3100 professionals, including 800 doctors and professors working in 11 research institutions, five hospitals and clinics, and several educational and publishing branches. It is the most respected and trusted group engaged in research, education, and practice in traditional Chinese medicine. About The Coca-Cola Company The Coca-Cola Company is the world’s largest nonalcoholic beverage company. Along with the Coca-Cola® trademark, recognized as the world’s most valuable brand, the company markets four of the world’s top five nonalcoholic sparkling beverage brands (including Coca-Cola®, Diet Coke®, Fanta® and Sprite® beverages), and a wide range of other nonalcoholic beverages, (including diet and light beverages, waters, juices and juice drinks, teas, coffees, and energy and sports drinks). Through the world’s largest beverage distribution system, consumers in more than 200 countries enjoy the company’s beverages at a rate exceeding 1.4 billion servings each day. ■ Contact details: China Academy of Chinese Medical Sciences Address: No.16 Nanxiaojie, Dongzhimen nei, Beijing 100700 P.R.China. Tel: +86 10 64016387 Email: [email protected] URL: www.cacms.ac.cn Contact Details: The Coca-Cola Company Address: P. O. Box 1734 Atlanta, GA 30301 USA Tel: +1 (404) 515 4400 Fax: +1 (404) 515 0430 URL: www.thecoca-colacompany.com www.asiabiotech.com Volume 11 > Number 21 > 2007 ■ 1421 [ Industry Watch ] CHINA Greater China Corporation to Open TRT Wellness Centers reater China Corporation announced the formation of Tong Ren Tang Wellness Corporation in partnership with TRT USA Corp.
    [Show full text]
  • Etf Harvest Msci China a Index
    HARVEST FUNDS (HONG KONG) ETF (AN UMBRELLA UNIT TRUST ESTABLISHED IN HONG KONG) HARVEST MSCI CHINA A INDEX ETF (A SUB-FUND OF THE HARVEST FUNDS (HONG KONG) ETF) UNAUDITED SEMI-ANNUAL REPORT 30 JUNE 2019 www.harvestglobal.com.hk Harvest Global Investments HARVEST FUNDS (HONG KONG) ETF (AN UMBRELLA UNIT TRUST ESTABLISHED IN HONG KONG) HARVEST MSCI CHINA A INDEX ETF (A SUB-FUND OF THE HARVEST FUNDS (HONG KONG) ETF) SEMI-ANNUAL REPORT 1ST JANUARY 2019 TO 30TH JUNE 2019 RESTRICTED HARVEST MSCI CHINA A INDEX ETF (A SUB-FUND OF THE HARVEST FUNDS (HONG KONG) ETF) CONTENTS PAGE Report of the Manager to the Unitholders 1 - 2 Statement of Financial Position (Unaudited) 3 Statement of Comprehensive Income (Unaudited) 4 Statement of Changes in Net Assets Attributable to Unitholders (Unaudited) 5 Statement of Cash Flows (Unaudited) 6 Investment Portfolio (Unaudited) 7 – 27 Statement of Movements in Investment Portfolio (Unaudited) 28 – 67 Performance Record (Unaudited) 68 Underlying Index Constituent Stocks Disclosure (Unaudited) 69 Report on Investment Overweight (Unaudited) 70 Management and Administration 71 - 73 RESTRICTED HARVEST MSCI CHINA A INDEX ETF (A SUB-FUND OF THE HARVEST FUNDS (HONG KONG) ETF) REPORT OF THE MANAGER TO THE UNITHOLDERS Fund Performance A summary of the performance of the Sub-Fund1 is given below (as at 30 June 2019): Harvest MSCI China A Index ETF 1H-2019 (without dividend reinvested) 2 MSCI China A Index 27.12% 3 Harvest MSCI China A Index ETF NAV-to-NAV (RMB Counter) 27.15% 4 Harvest MSCI China A Index ETF Market-to-Market (RMB Counter) 26.56% 3 Harvest MSCI China A Index ETF NAV-to-NAV (HKD Counter) 26.84% 4 Harvest MSCI China A Index ETF Market-to-Market (HKD Counter) 27.34% Source: Harvest Global Investments Limited, Bloomberg.
    [Show full text]
  • 43Gdy6nm9dgg55.Pdf
    Investment Manager: AMP Capital Investors Limited ABN 59 001 777 591 | AFSL 232497 Issuer and Responsible Entity: BetaShares Capital Ltd ABN 78 139 566 868 | AFSL 341181 28 February 2017 Market Announcements Office ASX Limited AMP CAPITAL DYNAMIC MARKETS FUND (HEDGE FUND) (ASX CODE: DMKT) QUARTERLY PORTFOLIO DISCLOSURE We advise that the Fund’s portfolio as at 30 December 2016 comprised the following holdings: Security Weighting (%) Security Weighting (%) ETFs* SPDR S&P/ASX200 Fund 9.82 Vanguard Value ETF 2.09 Vanguard FTSE Emgerging Markets ETF 8.75 Vanguard Materials ETF 1.95 BetaShares FTSE RAFI AU 200 5.18 iShares Global Materials ETF 1.93 iShares Global Financials ETF 3.21 Topix-17 Banks ETF 1.70 Vaneck Vectors Russia ETF 2.74 Lyxor ETF STOXX Europe 600 Banks 1.61 SPDR Bank ETF 2.67 Vanguard Energy ETF 1.61 *Please note underlying ETF exposures are provided below on a weighted consolidated look through basis. AMP Capital Investors Limited 50 Bridge Street Sydney NSW 2000 Australia Client Services 1800 658 404 8.30am-5.30pm | [email protected] ampcapital.com.au For personal use only Important information: This information has been prepared by BetaShares Capital Ltd (ACN 139 566 868 AFS Licence 341181) ("BetaShares") the Responsible Entity and Issuer of the Fund. AMP Capital Investors Limited (“AMP Capital”) (ABN 59 001 777 591, and AFSL 232497) is the investment manager of the Fund and has been appointed by the Responsible Entity to provide investment management and associated services in respect of the Fund. It is general information only and does not take into account any person’s objectives, financial situation or needs.
    [Show full text]
  • Potential Opportunities from One of the Fastest Growing Major Global Healthcare Markets1
    KURE 12/31/2020 China Healthcare: Potential Opportunities From One Of The Fastest Growing Major Global Healthcare Markets1 An Overview of the KraneShares MSCI All China Health Care Index ETF (Ticker: KURE) 1. Major healthcare markets defined as top five global markets by the World Health Organization. Data from the World Health Organization as of 12/31/2017, last updated on 4/7/2020. [email protected] 1 Introduction to KraneShares About KraneShares Krane Funds Advisors, LLC is the investment manager for KraneShares ETFs. Our suite of China focused ETFs provides investors with solutions to capture China’s importance as an essential element of a well-designed investment portfolio. We strive to provide innovative, first to market strategies that have been developed based on our strong partnerships and our deep knowledge of investing. We help investors current on global market trends and aim to provide meaningful diversification. Krane Funds Advisors, LLC is majority owned by China International Capital Corporation (CICC). 2 Investment Strategy: KURE seeks to measure the performance of MSCI China All Shares Health Care 10/40 Index. The Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the health care sector. The securities in the Index include all types of publicly issued shares of Chinese issuers, which are listed in Mainland China, Hong Kong and the KURE United States. Issuers eligible for inclusion must be classified under the Global Industry Classification Standard (GICS) as engaged in the healthcare sector. The issuers included in the Underlying Index may include small-cap, mid-cap and large-cap companies.
    [Show full text]
  • Annual Report DBX ETF Trust
    May 31, 2021 Annual Report DBX ETF Trust Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF (ASHS) Xtrackers MSCI All China Equity ETF (CN) Xtrackers MSCI China A Inclusion Equity ETF (ASHX) DBX ETF Trust Table of Contents Page Shareholder Letter ....................................................................... 1 Management’s Discussion of Fund Performance ............................................. 3 Performance Summary Xtrackers Harvest CSI 300 China A-Shares ETF ........................................... 6 Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF .................................. 8 Xtrackers MSCI All China Equity ETF .................................................... 10 Xtrackers MSCI China A Inclusion Equity ETF ............................................ 12 Fees and Expenses ....................................................................... 14 Schedule of Investments Xtrackers Harvest CSI 300 China A-Shares ETF ........................................... 15 Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF .................................. 20 Xtrackers MSCI All China Equity ETF .................................................... 28 Xtrackers MSCI China A Inclusion Equity ETF ............................................ 33 Statements of Assets and Liabilities ........................................................ 42 Statements of Operations ................................................................. 43 Statements of Changes in Net
    [Show full text]
  • China Chemical Drug Sector Research Analysts INITIATION
    19 January 2015 Asia Pacific/China Equity Research Major Pharmaceuticals (Healthcare CN (Asia)) China Chemical Drug Sector Research Analysts INITIATION Zen Zhou 852 2101 7640 [email protected] Big sheep run faster Iris Wang 852 2101 7646 Figure 1: Using three criteria to screen chemical drug companies [email protected] Strong Attractive Capable R&D commercialization Overall ranking valuation capability Hengrui Sihuan CSPC Huahai Salubris Dawnrays x Sino Biopharm Luye Humanwell CMS Fosun Pharma - Highest, - Lowest. Overall ranking is valued by weighted average of three criteria (Capable R&D:35%, Strong commercialization capability: 35%, Attractive valuation: 30%) Note: The four companies labelled with blue colour are initiated by us this time. Source: Credit Suisse ■ Stay on the sweet spot (Oncology and CNS). We forecast China’s chemical drug sector to deliver 15% CAGR in 2014–16, reaching about Rmb900 bn market size; however, the growth rate will vary among different therapeutic areas due to the higher morbidity rate for chronic diseases related to ageing population, urbanisation and lifestyle changes. We expect oncology drugs (17.5% CAGR in 2014–16) and CNS drugs (18.1% CAGR in 2014–16) to gain market share, while anti-infective drugs (9.5% CAGR in 2014–16) to lose market share. ■ Only the leader will win. China’s chemical drug market is fragmented compared to the global level (CR10: 15% vs 42%), but we see the domestic leading companies are gaining market share. We believe the trend of consolidation will stay stable, driven by: (1) higher barrier for R&D, (2) higher barrier for manufacturers, (3) favourable tender policy and (4) more M&A.
    [Show full text]
  • Changing Healthcare
    Changing Healthcare ACTCM students learn how to apply ancient wisdom to Apply Online Master of Science in Traditional Chinese Medicine www.actcm.edu/apply Doctorate of Acupuncture and Chinese Medicine modern healthcare practices. Chinese Medicine is a medical Submit the following: • Official Transcript(s) from all system that has been used for thousands of years to prevent, colleges attended • Personal Statement diagnose, and treat disease. It is based on the belief that • 2 Letters of Recommendation qi (the body’s vital energy) flows along meridians (channels) • Completed Application Form • Professional Resume in the body and keeps a person’s physical, spiritual, emotional • Application Fee and mental health in balance. Chinese medical modalities • 2 Passport Size Photos include acupuncture, diet, herbal therapy, meditation, ACTCM Admissions Team 455 Arkansas Street massage and exercise. San Francisco, CA 94107 Phone: (415)401-0464 Email: [email protected] www.actcm.edu ACTCM Graduates Lead the Field As… Acupuncturists Without Borders who give Acupuncturists who set up private practices medical aid to communities in crisis. around the country. Herbalists who grow herbs and create Educators who publish on TCM, wellness, herbal pharmacies. nutrition, and holistic healthcare. Healers who establish integrative health centers. Practitioners who are leading the way towards integrative healthcare in hospitals and clinics. Experts at forefront of healthcare research, ACTCM is Transforming AOM Education teaching and policy making. Through our merger with California Institute of Integral Studies (CIIS) we are advancing opportunities for the holistic care of mind, body and spirit. ACTCM at CIIS is creating clinic services that explore the interface between Chinese medicine and mental health.
    [Show full text]